Condition: Mayer Rokitansky Kuster Hauser Syndrome · Sponsor: Imagine Institute
In order to understand the molecular mechanisms leading to Mayer-Rokitansky-Kuster-Hauser syndrome (MRKH), the research team has to identify molecular bases of this anomaly. Toward this goal, the research team would like to include in the study patients with MRKH syndrome, as well as their healthy relatives, in order to perform genetic analyses, especially whole exome sequencing. This study has been set up in order to collect biological samples from patients with MRKH and their relatives.
This description comes directly from the study's public registry record.
Stanislas Lyonnet · +33 1 44 49 51 36 · stanislas.lyonnet@inserm.fr
Anna Pelet · +33 1 42 75 43 08 · anna.pelet@inserm.fr
Always discuss trial participation with your own doctor first.
| Necker - Enfants malades hospital | Paris, France | Recruiting |
| Institut Mutualiste Montsouris | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02967822